-transparent.png){kind=logo}
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common enzyme defect with a wide range of clinical manifestations that can be severe. A variety of factors including many medications can induce hemolytic episodes. Screening for G6PD deficiency is required before use of some drugs especially primaquine or dapsone.
Related Publications
M Mura, and
R Saidi, and
A Wolf, and
J L Moalic, and
M Oliver
January 1960,
Pediatrie,
M Mura, and
R Saidi, and
A Wolf, and
J L Moalic, and
M Oliver
June 1964,
Minerva medica,
M Mura, and
R Saidi, and
A Wolf, and
J L Moalic, and
M Oliver
April 1965,
Seminars in hematology,
M Mura, and
R Saidi, and
A Wolf, and
J L Moalic, and
M Oliver
May 1985,
The Mount Sinai journal of medicine, New York,
M Mura, and
R Saidi, and
A Wolf, and
J L Moalic, and
M Oliver
January 1966,
Polskie Archiwum Medycyny Wewnetrznej,
M Mura, and
R Saidi, and
A Wolf, and
J L Moalic, and
M Oliver
September 1966,
Deutsche medizinische Wochenschrift (1946),
M Mura, and
R Saidi, and
A Wolf, and
J L Moalic, and
M Oliver
December 1960,
Federation proceedings,
M Mura, and
R Saidi, and
A Wolf, and
J L Moalic, and
M Oliver
January 1964,
Europa medica. [Edicion espanola],
M Mura, and
R Saidi, and
A Wolf, and
J L Moalic, and
M Oliver
January 1966,
Polskie Archiwum Medycyny Wewnetrznej,
M Mura, and
R Saidi, and
A Wolf, and
J L Moalic, and
M Oliver
January 1966,
The American journal of the medical sciences,
